Need immediate assistance? Call 1-518-730-0559 (Us-Canada Toll Free) or Contact Us

 

Implantable Drug-Eluting Devices Market – Global Industry Analysis and Opportunity Assessment, 2019-2029

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusion & Exclusion/ Scope of the Report

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product Development Trends

4. Key Success Factors

    4.1. New Product Launches & Regulatory Approvals

    4.2. Key Strategies Followed By Manufacturers

5. Market Context

    5.1. Product Adoption / Application Analysis

    5.2. Regulatory Scenario

    5.3. Value Chain Analysis 

    5.4. Reimbursement Scenario

6. Global Implantable Drug-Eluting Devices Market Demand Analysis 2014-2018 and Forecast, 2019-2029

    6.1. Historical Market Volume (Units) Analysis, 2014-2018  

    6.2. Current and Future Market Volume (Units) Projections, 2018-2028

    6.3. Y-o-Y Growth Trend Analysis

7. Global Implantable Drug-Eluting Devices Market Pricing Analysis

    7.1. Regional Pricing Analysis By Product Type

    7.2. Pricing Break-up

        7.2.1. Manufacturer Level Pricing

        7.2.2. Distributor Level Pricing

    7.3. Global Average Pricing Analysis Benchmark

8. Global Implantable Drug-Eluting Devices Market Demand (in Value or Size in US$ Mn) Analysis 2014-2018 and Forecast, 2019-2029

    8.1. Historical Market Value (US$ Mn) Analysis, 2014-2018

    8.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029

        8.2.1. Y-o-Y Growth Trend Analysis

        8.2.2. Absolute $ Opportunity Analysis

9. Market Background

    9.1. Macro-Economic Factors

        9.1.1. Global GDP Growth Outlook

        9.1.2. Global Healthcare Outlook 

        9.1.3. Per Capita Healthcare Expenditure Outlook

    9.2. Forecast Factors – Relevance & Impact

    9.3. Market Dynamics

        9.3.1. Drivers

        9.3.2. Restraints

        9.3.3. Opportunity Analysis

10. Global Implantable Drug-Eluting Devices Market Analysis 2014-2018 and Forecast 2019-2029, by Technology 

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) Analysis By Technology, 2014 – 2018

    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Technology, 2019 – 2029

        10.3.1. Active Drug-Eluting Device

        10.3.2. Passive Drug-Eluting Device

            10.3.2.1. Biodegradable implants

            10.3.2.2. Non-biodegradable implants

    10.4. Market Attractiveness Analysis By Technology 

11. Global Implantable Drug-Eluting Devices Market Analysis 2014-2018 and Forecast 2019-2029, by Product Type

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2014 – 2018

    11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2019 – 2029

        11.3.1. Implantable Drug Infusion Pumps

        11.3.2. Intraocular Drug-Eluting Devices

        11.3.3. Contraceptive Drug-Eluting Devices

        11.3.4. Buprenorphine Implant

        11.3.5. Drug-Eluting Stents 

        11.3.6. Others

    11.4. Market Attractiveness Analysis By Product Type

12. Global Implantable Drug-Eluting Devices Market Analysis 2014-2018 and Forecast 2019-2029, by Application

    12.1. Introduction / Key Findings

    12.2. Historical Market Size (US$ Mn) Analysis By Application, 2014 – 2018

    12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2019 – 2029

        12.3.1. Diabetic Macular Edema

        12.3.2. Birth Control/Contraception

        12.3.3. Opioid Addiction

        12.3.4. Cardiovascular 

        12.3.5. Ophthalmology

        12.3.6. Oncology

        12.3.7. Pain Management

    12.4. Market Attractiveness Analysis By Application

13. Global Implantable Drug-Eluting Devices Market Analysis 2014-2018 and Forecast 2019-2029, by Implantation Type

    13.1. Introduction / Key Findings

    13.2. Historical Market Size (US$ Mn) Analysis By Implantation Type, 2014 – 2018

    13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Implantation Type, 2019 – 2029

        13.3.1. Intravaginal 

        13.3.2. Intravascular

        13.3.3. Intraocular

        13.3.4. Intrathecal

        13.3.5. Subcutaneous

        13.3.6. Intrauterine

    13.4. Market Attractiveness Analysis By Implantation Type

14. Global Implantable Drug-Eluting Devices Market Analysis 2014-2018 and Forecast 2019-2029, by End User

    14.1. Introduction / Key Findings

    14.2. Historical Market Size (US$ Mn) Analysis By End User, 2014 – 2018

    14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2019 – 2029

        14.3.1. Hospitals

        14.3.2. Ambulatory Surgical Centres

        14.3.3. Optical Care Centres

        14.3.4. Cardiac Surgery Centres

        14.3.5. Office based settings

        14.3.6. Others

    14.4. Market Attractiveness Analysis By End User

15. Global Implantable Drug-Eluting Devices Market Analysis 2014-2018 and Forecast 2019-2029, by Region

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) Analysis By Region, 2014 – 2018

    15.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2019 – 2029

        15.3.1. North America

        15.3.2. Latin America

        15.3.3. Europe

        15.3.4. Middle East and Africa (MEA)

        15.3.5. East Asia

        15.3.6. South Asia

        15.3.7. Oceania

    15.4. Market Attractiveness Analysis By Region

16. North America Implantable Drug-Eluting Devices Market Analysis 2014-2018 and Forecast 2019-2029

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 –   2018

    16.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 – 2029

        16.3.1.  By Country

            16.3.1.1. U.S.

            16.3.1.2. Canada

        16.3.2. By Technology

        16.3.3. By Product Type

        16.3.4. By Application

        16.3.5. By Implantation Type

        16.3.6. By End User

    16.4. Market Attractiveness Analysis

        16.4.1. By Country

        16.4.2. By Technology

        16.4.3. By Product Type

        16.4.4. By Application

        16.4.5. By Implantation Type

        16.4.6. By End User

    16.5. Key Market Participants – Intensity Mapping

    16.6. Drivers and Restraints – Impact Analysis

17. Latin America Implantable Drug-Eluting Devices Market Analysis 2014-2018 and Forecast 2019-2029

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 –  2018

    17.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 – 2029

        17.3.1.  By Country

            17.3.1.1. Brazil

            17.3.1.2. Mexico

            17.3.1.3. Rest of Latin America

        17.3.2. By Technology

        17.3.3. By Product Type

        17.3.4. By Application

        17.3.5. By Implantation Type

        17.3.6. By End User

    17.4. Market Attractiveness Analysis

        17.4.1. By Country

        17.4.2. By Technology

        17.4.3. By Product Type

        17.4.4. By Application

        17.4.5. By Implantation Type

        17.4.6. By End User

    17.5. Key Market Participants – Intensity Mapping

    17.6. Drivers and Restraints – Impact Analysis

18. Europe Implantable Drug-Eluting Devices Market Analysis 2014-2018 and Forecast 2019-2029

    18.1. Introduction

    18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 – 2018

    18.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 – 2029

        18.3.1.  By Country

            18.3.1.1. Germany

            18.3.1.2. Italy

            18.3.1.3. France

            18.3.1.4. U.K.

            18.3.1.5. Spain

            18.3.1.6. BENELUX

            18.3.1.7. Russia

            18.3.1.8. Rest of Europe

        18.3.2. By Technology

        18.3.3. By Product Type

        18.3.4. By Application

        18.3.5. By Implantation Type

        18.3.6. By End User

    18.4. Market Attractiveness Analysis

        18.4.1. By Country

        18.4.2. By Technology

        18.4.3. By Product Type

        18.4.4. By Application

        18.4.5. By Implantation Type

        18.4.6. By End User

    18.5. Key Market Participants – Intensity Mapping

    18.6. Drivers and Restraints – Impact Analysis

19. South Asia Implantable Drug-Eluting Devices Market Analysis 2014-2018 and Forecast 2019-2029

    19.1. Introduction

    19.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 – 2018

    19.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 – 2029

        19.3.1.  By Country

            19.3.1.1. India

            19.3.1.2. Thailand

            19.3.1.3. Indonesia

            19.3.1.4. Malaysia

            19.3.1.5. Rest of South Asia

        19.3.2. By Technology

        19.3.3. By Product Type

        19.3.4. By Application

        19.3.5. By Implantation Type

        19.3.6. By End User

    19.4. Market Attractiveness Analysis

        19.4.1. By Country

        19.4.2. By Technology

        19.4.3. By Product Type

        19.4.4. By Application

        19.4.5. By Implantation Type

        19.4.6. By End User

    19.5. Key Market Participants – Intensity Mapping

    19.6. Drivers and Restraints – Impact Analysis

20. East Asia Implantable Drug-Eluting Devices Market Analysis 2014-2018 and Forecast 2019-2029

    20.1. Introduction

    20.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 – 2018

    20.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 – 2029

        20.3.1.  By Country

            20.3.1.1. China

            20.3.1.2. Japan

            20.3.1.3. South Korea

        20.3.2. By Technology

        20.3.3. By Product Type

        20.3.4. By Application

        20.3.5. By Implantation Type

        20.3.6. By End User

    20.4. Market Attractiveness Analysis

        20.4.1. By Country

        20.4.2. By Technology

        20.4.3. By Product Type

        20.4.4. By Application

        20.4.5. By Implantation Type

        20.4.6. By End User

    20.5. Key Market Participants – Intensity Mapping

    20.6. Drivers and Restraints – Impact Analysis

21. Oceania Implantable Drug-Eluting Devices Market Analysis 2014-2018 and Forecast 2019-2029

    21.1. Introduction

    21.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 – 2018

    21.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 – 2029

        21.3.1.  By Country

            21.3.1.1. Australia

            21.3.1.2. New Zealand

        21.3.2. By Technology

        21.3.3. By Product Type

        21.3.4. By Application

        21.3.5. By Implantation Type

        21.3.6. By End User

    21.4. Market Attractiveness Analysis

        21.4.1. By Country

        21.4.2. By Technology

        21.4.3. By Product Type

        21.4.4. By Application

        21.4.5. By Implantation Type

        21.4.6. By End User

    21.5. Key Market Participants – Intensity Mapping

    21.6. Drivers and Restraints – Impact Analysis

22. Middle East and Africa Implantable Drug-Eluting Devices Market Analysis 2014-2018 and Forecast 2019-2029

    22.1. Introduction

    22.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 – 2018

    22.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 – 2029

        22.3.1.  By Country

            22.3.1.1. GCC Countries

            22.3.1.2. Turkey

            22.3.1.3. Northern Africa

            22.3.1.4. South Africa

            22.3.1.5. Rest of Middle East and Africa

        22.3.2. By Technology

        22.3.3. By Product Type

        22.3.4. By Application

        22.3.5. By Implantation Type

        22.3.6. By End User

    22.4. Market Attractiveness Analysis

        22.4.1. By Country

        22.4.2. By Technology

        22.4.3. By Product Type

        22.4.4. By Application

        22.4.5. By Implantation Type

        22.4.6. By End User

    22.5. Key Market Participants – Intensity Mapping

    22.6. Drivers and Restraints – Impact Analysis

23. Emerging Countries Implantable Drug-Eluting Devices Market Analysis 2014-2018 and Forecast 2019-2029

    23.1. Introduction

        23.1.1. Market Value Proportion Analysis, By Key Countries

        23.1.2. Global Vs. Country Growth Comparison

    23.2. China Implantable Drug-Eluting Devices Market Analysis

        23.2.1. Introduction

        23.2.2. Market Value Proportion Analysis by Market Taxonomy

        23.2.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            23.2.3.1. By Technology

            23.2.3.2. By Product Type

            23.2.3.3. By Application

            23.2.3.4. By Implantation Type

            23.2.3.5. By End User

        23.2.4. China Implantable Drug-Eluting Devices Market – Competition Landscape

    23.3. India Implantable Drug-Eluting Devices Market Analysis

        23.3.1. Introduction

        23.3.2. Market Value Proportion Analysis by Market Taxonomy

        23.3.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            23.3.3.1. By Technology

            23.3.3.2. By Product Type

            23.3.3.3. By Application

            23.3.3.4. By Implantation Type

            23.3.3.5. By End User

        23.3.4. India Implantable Drug-Eluting Devices Market – Competition Landscape

    23.4. Brazil Implantable Drug-Eluting Devices Market Analysis

        23.4.1. Introduction

        23.4.2. Market Value Proportion Analysis by Market Taxonomy

        23.4.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            23.4.3.1. By Technology

            23.4.3.2. By Product Type

            23.4.3.3. By Application

            23.4.3.4. By Implantation Type

            23.4.3.5. By End User

        23.4.4. Brazil Implantable Drug-Eluting Devices Market – Competition Landscape

24. Market Structure Analysis

    24.1. Market Structure Analysis by Tier of Companies

    24.2. Market Share Analysis

    24.3. Market Concentration

    24.4. Market Presence Analysis

25. Competition Analysis

    25.1. Competition Dashboard

    25.2. Competition Deep Dive 

        25.2.1. Pfizer Inc.

            25.2.1.1. Overview

            25.2.1.2. Product Portfolio

            25.2.1.3. Sales Footprint

            25.2.1.4. Strategy Overview

        25.2.2. Medtronic Inc.

            25.2.2.1. Overview

            25.2.2.2. Product Portfolio

            25.2.2.3. Sales Footprint

            25.2.2.4. Strategy Overview

        25.2.3. Merck & Co., In

            25.2.3.1. Overview

            25.2.3.2. Product Portfolio

            25.2.3.3. Sales Footprint

            25.2.3.4. Strategy Overview

        25.2.4. Bayer AG 

            25.2.4.1. Overview

            25.2.4.2. Product Portfolio

            25.2.4.3. Sales Footprint

            25.2.4.4. Strategy Overview

        25.2.5. Johnson & Johnson

            25.2.5.1. Overview

            25.2.5.2. Product Portfolio

            25.2.5.3. Sales Footprint

            25.2.5.4. Strategy Overview

        25.2.6. SurModics Inc.

            25.2.6.1. Overview

            25.2.6.2. Product Portfolio

            25.2.6.3. Sales Footprint

            25.2.6.4. Strategy Overview

        25.2.7. AstraZeneca Plc.

            25.2.7.1. Overview

            25.2.7.2. Product Portfolio

            25.2.7.3. Sales Footprint

            25.2.7.4. Strategy Overview

        25.2.8. Boston Scientific Corporation

            25.2.8.1. Overview

            25.2.8.2. Product Portfolio

            25.2.8.3. Sales Footprint

            25.2.8.4. Strategy Overview

        25.2.9. Titan Pharmaceuticals, Inc.

            25.2.9.1. Overview

            25.2.9.2. Product Portfolio

            25.2.9.3. Sales Footprint

            25.2.9.4. Strategy Overview

        25.2.10. BIOTRONIK, INC.

            25.2.10.1. Overview

            25.2.10.2. Product Portfolio

            25.2.10.3. Sales Footprint

            25.2.10.4. Strategy Overview

        25.2.11. Abbott Laboratories

            25.2.11.1. Overview

            25.2.11.2. Product Portfolio

            25.2.11.3. Sales Footprint

            25.2.11.4. Strategy Overview

        25.2.12. Allergan, Inc.

            25.2.12.1. Overview

            25.2.12.2. Product Portfolio

            25.2.12.3. Sales Footprint

            25.2.12.4. Strategy Overview

        25.2.13. Bausch and Lomb, Inc.

            25.2.13.1. Overview

            25.2.13.2. Product Portfolio

            25.2.13.3. Sales Footprint

            25.2.13.4. Strategy Overview

        25.2.14. Alimera Sciences

            25.2.14.1. Overview

            25.2.14.2. Product Portfolio

            25.2.14.3. Sales Footprint

            25.2.14.4. Strategy Overview

        25.2.15. REVA Medical, Inc.

            25.2.15.1. Overview

            25.2.15.2. Product Portfolio

            25.2.15.3. Sales Footprint

            25.2.15.4. Strategy Overview

26. Assumptions and Acronyms Used

27. Research Methodology

Custom Market Research Services

MRRSE offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Get A Free Custom Research Quote